Advances in clinical trial design: Weaving tomorrow's TB treatments

Christian Lienhardt and co-authors discuss the conclusions of the PLOS Medicine Collection on advances in clinical trial design for development of new tuberculosis treatments.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2020-02, Vol.17 (2), p.e1003059-e1003059
Hauptverfasser:	Lienhardt, Christian, Nunn, Andrew, Chaisson, Richard, Vernon, Andrew A, Zignol, Matteo, Nahid, Payam, Delaporte, Eric, Kasaeva, Tereza
Format:	Artikel
Sprache:	eng
Schlagworte:	Animal models Antibiotics Antiretroviral drugs Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Bacilli Bacteriology Chemotherapy Clinical trials Clinical Trials as Topic - economics Clinical Trials as Topic - methods Clinical Trials, Phase II as Topic - economics Clinical Trials, Phase II as Topic - methods Clinical Trials, Phase III as Topic - economics Clinical Trials, Phase III as Topic - methods Collection Review Drug Development Drug dosages Drug Evaluation, Preclinical Hepatitis HIV Human health and pathology Human immunodeficiency virus Humans Infectious diseases Life Sciences Mathematical models Medication Adherence Medicine and Health Sciences Microbiology and Parasitology Pharmaceutical sciences Pharmacodynamics Pharmacokinetics R&D Research & development Research and analysis methods Rifampin Risk factors Sputum Time Factors Translational Medical Research Tuberculosis Tuberculosis - drug therapy Vulnerable Populations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Christian Lienhardt and co-authors discuss the conclusions of the PLOS Medicine Collection on advances in clinical trial design for development of new tuberculosis treatments.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1003059